CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Dublin, Feb. 17, 2017 -- Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Thousand by the following Dosage Forms:
- Injectables
- Solid Dosage Forms
- Liquid & Semi-solid Dosage Forms
The report profiles 112 companies including many key and niche players such as
- Aenova Group (Germany)
- Ajinomoto Althea, Inc. (US)
- Albany Molecular Research Inc. (US)
- Alcami Corporation (US)
- Baxter International, Inc. (US)
- Boehringer Ingelheim GmbH (Germany)
- Catalent Pharma Solutions, Inc. (US)
- Cobra Biologics Holding AB (Sweden)
- CordenPharma International (Germany)
- Dishman Group (India)
- DPx Holdings B.V. (US)
- Fareva Group (Luxembourg)
- Famar Health Care Services (Greece)
- Hospira, Inc. (US)
- Jubilant Life Sciences Limited (India)
- Kemwell Biopharma Pvt. Ltd. (India)
- Lonza Group Ltd. (Switzerland)
- LTS Lohmann Therapie-Systeme AG (Germany)
- NextPharma Technologies Holding Ltd. (UK)
- Nipro Pharma Corporation (Japan)
- Recipharm AB (Sweden)
- Vetter Pharma International GmbH (Germany)
Key Topics Covered:
1. Industry Overview
2. Market Trends & Drivers
3. Competitive Landscape
4. Service Overview
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 112 (including Divisions/Subsidiaries 125)
- The United States (54)
- Canada (2)
- Japan (7)
- Europe (40)
- - France (6)
- - Germany (10)
- - The United Kingdom (7)
- - Italy (3)
- - Spain (2)
- - Rest of Europe (12)
- Asia-Pacific (Excluding Japan) (21)
- Middle East (1)
For more information about this report visit http://www.researchandmarkets.com/research/ptddk8/pharmaceutical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals, Pharmaceutical Manufacturing
